GO
Loading...

Cramer: Biogen Idec's Profit Pipeline

Thursday, 26 Jan 2012 | 6:25 PM ET

Mad Money's Cramer, takes a look at Biogen Idec's medical breakthrough drugs and its near-term catalysts for growth this year.